United States High-density Multiplexed Diagnostic Assays Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 High-density Multiplexed Diagnostic Assays Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States High-density Multiplexed Diagnostic Assays Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States High-density Multiplexed Diagnostic Assays Overall Market Size
2.1 United States High-density Multiplexed Diagnostic Assays Market Size: 2021 VS 2027
2.2 United States High-density Multiplexed Diagnostic Assays Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top High-density Multiplexed Diagnostic Assays Players in United States Market
3.2 Top United States High-density Multiplexed Diagnostic Assays Companies Ranked by Revenue
3.3 United States High-density Multiplexed Diagnostic Assays Revenue by Companies
3.4 Top 3 and Top 5 High-density Multiplexed Diagnostic Assays Companies in United States Market, by Revenue in 2020
3.5 Companies High-density Multiplexed Diagnostic Assays Product Type
3.6 Tier 1, Tier 2 and Tier 3 High-density Multiplexed Diagnostic Assays Players in United States Market
3.6.1 List of Tier 1 High-density Multiplexed Diagnostic Assays Companies in United States
3.6.2 List of Tier 2 and Tier 3 High-density Multiplexed Diagnostic Assays Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States High-density Multiplexed Diagnostic Assays Market Size Markets, 2021 & 2027
4.1.2 High-density Multiplexed Diagnostic Assays
4.1.3 Very High-density Multiplexed Diagnostic Assays
4.2 By Type - United States High-density Multiplexed Diagnostic Assays Revenue & Forecasts
4.2.1 By Type - United States High-density Multiplexed Diagnostic Assays Revenue, 2016-2021
4.2.2 By Type - United States High-density Multiplexed Diagnostic Assays Revenue, 2022-2027
4.2.3 By Type - United States High-density Multiplexed Diagnostic Assays Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States High-density Multiplexed Diagnostic Assays Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Academic Research Institutes
5.1.4 Others
5.2 By Application - United States High-density Multiplexed Diagnostic Assays Revenue & Forecasts
5.2.1 By Application - United States High-density Multiplexed Diagnostic Assays Revenue, 2016-2021
5.2.2 By Application - United States High-density Multiplexed Diagnostic Assays Revenue, 2022-2027
5.2.3 By Application - United States High-density Multiplexed Diagnostic Assays Revenue Market Share, 2016-2027
6 High-density Multiplexed Diagnostic Assays Companies Profiles
6.1 Abbott
6.1.1 Abbott Company Details
6.1.2 Abbott Business Overview
6.1.3 Abbott High-density Multiplexed Diagnostic Assays Introduction
6.1.4 Abbott High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.1.5 Abbott Recent Developments
6.2 Hologic
6.2.1 Hologic Company Details
6.2.2 Hologic Business Overview
6.2.3 Hologic High-density Multiplexed Diagnostic Assays Introduction
6.2.4 Hologic High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.2.5 Hologic Recent Developments
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Details
6.3.2 Thermo Fisher Scientific Business Overview
6.3.3 Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Introduction
6.3.4 Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.3.5 Thermo Fisher Scientific Recent Developments
6.4 Luminex
6.4.1 Luminex Company Details
6.4.2 Luminex Business Overview
6.4.3 Luminex High-density Multiplexed Diagnostic Assays Introduction
6.4.4 Luminex High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.4.5 Luminex Recent Developments
6.5 Randox Laboratories
6.5.1 Randox Laboratories Company Details
6.5.2 Randox Laboratories Business Overview
6.5.3 Randox Laboratories High-density Multiplexed Diagnostic Assays Introduction
6.5.4 Randox Laboratories High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.5.5 Randox Laboratories Recent Developments
6.6 Gold Standard Diagnostics
6.6.1 Gold Standard Diagnostics Company Details
6.6.2 Gold Standard Diagnostics Business Overview
6.6.3 Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Introduction
6.6.4 Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.6.5 Gold Standard Diagnostics Recent Developments
6.7 F. Hoffmann-La Roche
6.7.1 F. Hoffmann-La Roche Company Details
6.7.2 F. Hoffmann-La Roche Business Overview
6.7.3 F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Introduction
6.7.4 F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.7.5 F. Hoffmann-La Roche Recent Developments
6.8 Agilent Technologies
6.8.1 Agilent Technologies Company Details
6.8.2 Agilent Technologies Business Overview
6.8.3 Agilent Technologies High-density Multiplexed Diagnostic Assays Introduction
6.8.4 Agilent Technologies High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.8.5 Agilent Technologies Recent Developments
6.9 Bio-Rad Laboratories
6.9.1 Bio-Rad Laboratories Company Details
6.9.2 Bio-Rad Laboratories Business Overview
6.9.3 Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Introduction
6.9.4 Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.9.5 Bio-Rad Laboratories Recent Developments
6.10 Erba Diagnostics
6.10.1 Erba Diagnostics Company Details
6.10.2 Erba Diagnostics Business Overview
6.10.3 Erba Diagnostics High-density Multiplexed Diagnostic Assays Introduction
6.10.4 Erba Diagnostics High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021)
6.10.5 Erba Diagnostics Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. High-density Multiplexed Diagnostic Assays Market Opportunities & Trends in United States Market
Table 2. High-density Multiplexed Diagnostic Assays Market Drivers in United States Market
Table 3. High-density Multiplexed Diagnostic Assays Market Restraints in United States Market
Table 4. Key Players of High-density Multiplexed Diagnostic Assays in United States Market
Table 5. Top High-density Multiplexed Diagnostic Assays Players in United States Market, Ranking by Revenue (2019)
Table 6. United States High-density Multiplexed Diagnostic Assays Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States High-density Multiplexed Diagnostic Assays Revenue Share by Companies, 2016-2021
Table 8. Companies High-density Multiplexed Diagnostic Assays Product Type
Table 9. List of Tier 1 High-density Multiplexed Diagnostic Assays Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 High-density Multiplexed Diagnostic Assays Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), 2022-2027
Table 17. Abbott Company Details
Table 18. Abbott Business Overview
Table 19. Abbott High-density Multiplexed Diagnostic Assays Product
Table 20. Abbott High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Abbott Recent Developments
Table 22. Hologic Company Details
Table 23. Hologic Business Overview
Table 24. Hologic High-density Multiplexed Diagnostic Assays Product
Table 25. Hologic High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Hologic Recent Developments
Table 27. Thermo Fisher Scientific Company Details
Table 28. Thermo Fisher Scientific Business Overview
Table 29. Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Product
Table 30. Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Thermo Fisher Scientific Recent Developments
Table 32. Luminex Company Details
Table 33. Luminex Business Overview
Table 34. Luminex High-density Multiplexed Diagnostic Assays Product
Table 35. Luminex High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Luminex Recent Developments
Table 37. Randox Laboratories Company Details
Table 38. Randox Laboratories Business Overview
Table 39. Randox Laboratories High-density Multiplexed Diagnostic Assays Product
Table 40. Randox Laboratories High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Randox Laboratories Recent Developments
Table 42. Gold Standard Diagnostics Company Details
Table 43. Gold Standard Diagnostics Business Overview
Table 44. Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Product
Table 45. Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Gold Standard Diagnostics Recent Developments
Table 47. F. Hoffmann-La Roche Company Details
Table 48. F. Hoffmann-La Roche Business Overview
Table 49. F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Product
Table 50. F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. F. Hoffmann-La Roche Recent Developments
Table 52. Agilent Technologies Company Details
Table 53. Agilent Technologies Business Overview
Table 54. Agilent Technologies High-density Multiplexed Diagnostic Assays Product
Table 55. Agilent Technologies High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Agilent Technologies Recent Developments
Table 57. Bio-Rad Laboratories Company Details
Table 58. Bio-Rad Laboratories Business Overview
Table 59. Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Product
Table 60. Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Bio-Rad Laboratories Recent Developments
Table 62. Erba Diagnostics Company Details
Table 63. Erba Diagnostics Business Overview
Table 64. Erba Diagnostics High-density Multiplexed Diagnostic Assays Product
Table 65. Erba Diagnostics High-density Multiplexed Diagnostic Assays Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Erba Diagnostics Recent Developments
List of FiguresFigure 1. High-density Multiplexed Diagnostic Assays Segment by Type
Figure 2. High-density Multiplexed Diagnostic Assays Segment by Application
Figure 3. United States High-density Multiplexed Diagnostic Assays Market Overview: 2020
Figure 4. United States High-density Multiplexed Diagnostic Assays Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States High-density Multiplexed Diagnostic Assays Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by High-density Multiplexed Diagnostic Assays Revenue in 2020
Figure 7. By Type - United States High-density Multiplexed Diagnostic Assays Revenue Market Share, 2016-2027
Figure 8. By Application - United States High-density Multiplexed Diagnostic Assays Revenue Market Share, 2016-2027
Figure 9. Abbott High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Hologic High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Luminex High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Randox Laboratories High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Agilent Technologies High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Erba Diagnostics High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)